Australia's most trusted
source of pharma news
Posted 30 November 2021 AM
Adelaide-based Mayne Pharma has gained approval from the TGA for its novel oral contraceptive Nextstellis, marking the first new contraceptive hormone in Australia in a decade.
Nextstellis is the first and only pill containing estetrol (E4), an estrogen produced by the human body during pregnancy, now derived from a plant source, and combined with drospirenone (DRSP).
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.